pharma · Cystic Fibrosis · Rheumatoid Arthritis · LKFT
Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV clinical programs — 6 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Yalelaan 60, 5th floor, Utrecht 3584 CM, NL
- Founded
- 2016
- Employees
- 9
- Programs
- 99
- Drugs
- 26
- Patents
- 0
Lakefront Biotherapeutics NV projects
6 ClinicalTrials.gov programs sponsored by Lakefront Biotherapeutics NV.
Lakefront Biotherapeutics NV has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Filgotinib
Lakefront Biotherapeutics NV
Ankylosing Spondylitis
3 trials -
Filgotinib
Lakefront Biotherapeutics NV
Crohn's Disease
2 trials -
Filgotinib
Lakefront Biotherapeutics NV
Psoriatic Arthritis
4 trials -
Filgotinib
Lakefront Biotherapeutics NV
Ulcerative Colitis
2 trials -
GLPG CAR T-cell therapy
Lakefront Biotherapeutics NV
Hematological Malignancies
1 trial -
GLPG1690
Lakefront Biotherapeutics NV
Idiopathic Pulmonary Fibrosis
2 trials
Frequently asked questions
How many clinical projects does Lakefront Biotherapeutics NV have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.